Reuters - A new type of diabetes pill being developed by Bristol-Myers Squibb and AstraZeneca was effective in a two-year study but more bladder and breast cancers have been found in patients treated with the drug.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment